Managing hypertension during the COVID-19 pandemic
Gespeichert in:
| Veröffentlicht in: | Journal of human hypertension 2020-06, Vol.34 (6), p.415-417 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 417 |
|---|---|
| container_issue | 6 |
| container_start_page | 415 |
| container_title | Journal of human hypertension |
| container_volume | 34 |
| creator | Nadar, Sunil K. Tayebjee, Muzahir H. Stowasser, Michael Byrd, James Brian |
| description | |
| doi_str_mv | 10.1038/s41371-020-0356-y |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7224587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A626945393</galeid><sourcerecordid>A626945393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c596t-34bfe291107bce2a45288b054b2aae36a6923e6f0e4a6bd95cccd64f5f7a48fb3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhi0EokvhB3BBKyEhLi7-dnxBqpavSkW9AFfLcSabVFk72AnS_nsctrRdBGgOlmaed8Yevwg9p-SMEl69yYJyTTFhBBMuFd4_QCsqtMJSMv0QrYiRBBsmyAl6kvM1IUuxeoxOeMkZzfQKsc8uuG0ftutuP0KaIOQ-hnUzpyU3dbDeXH27eIepWY8uNLDr_VP0qHVDhmc35yn6-uH9l80nfHn18WJzfom9NGrCXNQtMEMp0bUH5oRkVVUTKWrmHHDllGEcVEtAOFU3RnrvGyVa2Wonqrbmp-jtoe841ztoPIQpucGOqd-5tLfR9fa4EvrObuMPqxkTstKlweubBil-nyFPdtdnD8PgAsQ527KEElwzXtCXf6DXcU6hPK9QWmleVZz8n6IlOK_MHbV1A9g-tLHczi-j7bliygjJzTLx7C9UiV87jgHavuSPBK_uCTpww9TlOMxT-a98DNID6FPMOUF7uzJK7OIbe_CNLb6xi2_svmhe3N_1reK3UQrADkAeF2dAunv6v7v-BMSiyiY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414143389</pqid></control><display><type>article</type><title>Managing hypertension during the COVID-19 pandemic</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Nadar, Sunil K. ; Tayebjee, Muzahir H. ; Stowasser, Michael ; Byrd, James Brian</creator><creatorcontrib>Nadar, Sunil K. ; Tayebjee, Muzahir H. ; Stowasser, Michael ; Byrd, James Brian</creatorcontrib><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/s41371-020-0356-y</identifier><identifier>PMID: 32409727</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/75/243/785 ; 692/700/139 ; Angiotensin Receptor Antagonists - therapeutic use ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Betacoronavirus ; Coronavirus Infections - epidemiology ; Coronaviruses ; COVID-19 ; Editorial ; Epidemiology ; Health Administration ; Hospital patients ; Humans ; Hypertension ; Hypertension - drug therapy ; Medicine ; Medicine & Public Health ; Pandemics ; Pneumonia, Viral - epidemiology ; Public Health ; SARS-CoV-2 ; Severe acute respiratory syndrome</subject><ispartof>Journal of human hypertension, 2020-06, Vol.34 (6), p.415-417</ispartof><rights>Springer Nature Limited 2020</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>Springer Nature Limited 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c596t-34bfe291107bce2a45288b054b2aae36a6923e6f0e4a6bd95cccd64f5f7a48fb3</citedby><cites>FETCH-LOGICAL-c596t-34bfe291107bce2a45288b054b2aae36a6923e6f0e4a6bd95cccd64f5f7a48fb3</cites><orcidid>0000-0001-6186-3801</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32409727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nadar, Sunil K.</creatorcontrib><creatorcontrib>Tayebjee, Muzahir H.</creatorcontrib><creatorcontrib>Stowasser, Michael</creatorcontrib><creatorcontrib>Byrd, James Brian</creatorcontrib><title>Managing hypertension during the COVID-19 pandemic</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><subject>692/699/75/243/785</subject><subject>692/700/139</subject><subject>Angiotensin Receptor Antagonists - therapeutic use</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Betacoronavirus</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Editorial</subject><subject>Epidemiology</subject><subject>Health Administration</subject><subject>Hospital patients</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Public Health</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome</subject><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kk1v1DAQhi0EokvhB3BBKyEhLi7-dnxBqpavSkW9AFfLcSabVFk72AnS_nsctrRdBGgOlmaed8Yevwg9p-SMEl69yYJyTTFhBBMuFd4_QCsqtMJSMv0QrYiRBBsmyAl6kvM1IUuxeoxOeMkZzfQKsc8uuG0ftutuP0KaIOQ-hnUzpyU3dbDeXH27eIepWY8uNLDr_VP0qHVDhmc35yn6-uH9l80nfHn18WJzfom9NGrCXNQtMEMp0bUH5oRkVVUTKWrmHHDllGEcVEtAOFU3RnrvGyVa2Wonqrbmp-jtoe841ztoPIQpucGOqd-5tLfR9fa4EvrObuMPqxkTstKlweubBil-nyFPdtdnD8PgAsQ527KEElwzXtCXf6DXcU6hPK9QWmleVZz8n6IlOK_MHbV1A9g-tLHczi-j7bliygjJzTLx7C9UiV87jgHavuSPBK_uCTpww9TlOMxT-a98DNID6FPMOUF7uzJK7OIbe_CNLb6xi2_svmhe3N_1reK3UQrADkAeF2dAunv6v7v-BMSiyiY</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Nadar, Sunil K.</creator><creator>Tayebjee, Muzahir H.</creator><creator>Stowasser, Michael</creator><creator>Byrd, James Brian</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6186-3801</orcidid></search><sort><creationdate>20200601</creationdate><title>Managing hypertension during the COVID-19 pandemic</title><author>Nadar, Sunil K. ; Tayebjee, Muzahir H. ; Stowasser, Michael ; Byrd, James Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c596t-34bfe291107bce2a45288b054b2aae36a6923e6f0e4a6bd95cccd64f5f7a48fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>692/699/75/243/785</topic><topic>692/700/139</topic><topic>Angiotensin Receptor Antagonists - therapeutic use</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Betacoronavirus</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Editorial</topic><topic>Epidemiology</topic><topic>Health Administration</topic><topic>Hospital patients</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Public Health</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nadar, Sunil K.</creatorcontrib><creatorcontrib>Tayebjee, Muzahir H.</creatorcontrib><creatorcontrib>Stowasser, Michael</creatorcontrib><creatorcontrib>Byrd, James Brian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nadar, Sunil K.</au><au>Tayebjee, Muzahir H.</au><au>Stowasser, Michael</au><au>Byrd, James Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Managing hypertension during the COVID-19 pandemic</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>34</volume><issue>6</issue><spage>415</spage><epage>417</epage><pages>415-417</pages><issn>0950-9240</issn><eissn>1476-5527</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32409727</pmid><doi>10.1038/s41371-020-0356-y</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-6186-3801</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-9240 |
| ispartof | Journal of human hypertension, 2020-06, Vol.34 (6), p.415-417 |
| issn | 0950-9240 1476-5527 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7224587 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | 692/699/75/243/785 692/700/139 Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Betacoronavirus Coronavirus Infections - epidemiology Coronaviruses COVID-19 Editorial Epidemiology Health Administration Hospital patients Humans Hypertension Hypertension - drug therapy Medicine Medicine & Public Health Pandemics Pneumonia, Viral - epidemiology Public Health SARS-CoV-2 Severe acute respiratory syndrome |
| title | Managing hypertension during the COVID-19 pandemic |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A41%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Managing%20hypertension%20during%20the%20COVID-19%20pandemic&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=Nadar,%20Sunil%20K.&rft.date=2020-06-01&rft.volume=34&rft.issue=6&rft.spage=415&rft.epage=417&rft.pages=415-417&rft.issn=0950-9240&rft.eissn=1476-5527&rft_id=info:doi/10.1038/s41371-020-0356-y&rft_dat=%3Cgale_pubme%3EA626945393%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2414143389&rft_id=info:pmid/32409727&rft_galeid=A626945393&rfr_iscdi=true |